What's Happening?
A survey by RxBenefits reveals that 52% of U.S. employers would reconsider their pharmacy benefits plans if costs increased by 3%-10% annually. Pharmacy costs are the fastest-growing component of health benefits, with spending expected to rise significantly by 2029. Employers face challenges in providing high-quality pharmacy benefits amid unpredictable drug costs, driven by high-cost specialty drugs and emerging categories like GLP-1s. Employers are exploring innovative strategies to manage these costs, including carving out pharmacy benefits, flexible plan designs, and encouraging the use of generics and biosimilars.
AD
Why It's Important?
The rising cost of drugs poses a significant threat to the sustainability of employee benefits plans, impacting both employers and employees. As drug prices continue to climb, employers must find ways to balance cost control with the provision of comprehensive benefits. The adoption of innovative strategies to manage pharmacy expenses is crucial for maintaining employee satisfaction and ensuring the long-term viability of benefits plans. This issue highlights the need for collaboration between employers and pharmacy experts to navigate the complex landscape of drug pricing.
What's Next?
Employers are likely to continue seeking specialized solutions to manage pharmacy benefits costs, potentially leading to shifts in how benefits are structured and delivered. The focus on cost-effective alternatives and utilization management may drive changes in formulary design and prescription practices. As new high-cost drugs enter the market, employers will need to adapt their strategies to address these challenges while maintaining employee well-being.
